Frank Torti Roivant Sciences Ltd. (ROIV) insider trading activity

ROIV Quotes by TradingView

Frank Torti is President and Vant Chair of Roivant Sciences Ltd.. Currently has a direct ownership of 13.7 Million shares of ROIV, which is worth approximately $159 Million. The most recent transaction as insider was on Jul 30, 2025, when has been sold 13,736,547 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.7M
n/a 3M change
n/a 12M change
Total Value Held $159 Million

Frank Torti Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 30 2025
BUY
Grant, award, or other acquisition
-
13,736,547 Added 50.0%
13,736,547 Common Shares

Also insider at

IMVT
Immunovant, Inc. Healthcare
Director
SIOX
Sio Gene Therapies Inc. Healthcare
Director
ABUS
Arbutus Biopharma Corp Healthcare
Director
FT

Frank Torti

President and Vant Chair
New York, NY

Track Institutional and Insider Activities on ROIV

Follow Roivant Sciences Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

News

Receive news related to Roivant Sciences Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ROIV